The HDL receptor SR-BI: a new therapeutic target for atherosclerosis?
- 1 December 1999
- journal article
- review article
- Published by Elsevier in Molecular Medicine Today
- Vol. 5 (12), 518-524
- https://doi.org/10.1016/s1357-4310(99)01600-7
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiencyNature Genetics, 1999
- The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier diseaseNature Genetics, 1999
- Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1Nature Genetics, 1999
- The antiatherogenic role of high-density lipoprotein cholesterolThe American Journal of Cardiology, 1998
- High density lipoproteins and coronary heart diseaseAtherosclerosis, 1996
- PLASMA LIPID TRANSFER PROTEINSAnnual Review of Biochemistry, 1995
- In vitro and in vivo evidence for the role of HDL in reverse cholesterol transportBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1994
- Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)JAMA, 1993
- Plasma high density lipoproteins. Metabolism and relationship to atherogenesis.Journal of Clinical Investigation, 1990
- High-Density Lipoprotein — The Clinical Implications of Recent StudiesNew England Journal of Medicine, 1989